BioFocus to Screen Schering-Plough Candidates | GenomeWeb

NEW YORK (GenomeWeb News) – Galapagos subsidiary BioFocus DPI will conduct drug discovery screening and targeting studies over a one-year period for Schering-Plough, Galapagos said today.

Under the €2.8 million ($4.1 million) agreement, BioFocus will perform medicinal chemistry and studies of absorption, distribution, excretion, and pharmacokinetics for multiple Schering-Plough projects at two sites in Europe.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.